Skip to NavigationSkip to content

News

Novartis has signed a collaboration and license agreement with Pliant Therapeutics to develop and commercialise preclinical asset PLN-1474 which is...
Irish biopharma company Alkermes will complete up to 160 job cuts by end of this year and will take charge of around $15 million in the fourth...
Novartis has announced that the European Commission has approved a label update for the up-titration of Cosentyx (secukunumab) to 300mg for patients...
A new report has warned that poorly implemented electronic medication systems in the NHS could potentially lead to fatal medication errors.
The US FDA has approved GlaxoSmithKline’s Zejula (niraparib) for the use in advanced ovarian, fallopian tube, or primary peritoneal cancer patients...
The approval relates specifically to patients over the age of 12 who have at least one F508del mutation in the cystic fibrosis transmembrane...
A small study has found that the commonly prescribed medication for kids and teenagers with autism is no more effective than placebo in controlling...
Bristol Myers Squibb has lifted the curtain on new Phase 3 data for its blockbuster immunotherapy Opdivo (nivolumab), showing that the drug, when...
US firm Biogen is hoping for approval to bring about a treatment that could slow the onset of Alzheimer’s disease.
Takeda has acquired licensing for a first-in-class investigational coeliac disease therapy CNP-101/TAK-101. The Japanese pharma giant now has the...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches